Table of Contents

All the data and content are powered by ZXData, Learn more about ZXData

ZX Data private stock trade

Executive Summary

  • This quarter, reporting holders marked down their private portfolios by 3.7% ($ weighted) with an average mark-down of 9% (equal weighted). The period saw five companies declining for every two advancing companies.
  • Sentiment up:
  • Sentiment down:
  • In January, 40% of ZX Index companies showed a difference of 10% or less compared to Fund Marks, and 57% of ZX Index companies showed a difference of 20% or less compared to Fund Marks.

Heat Map: November 30th, 2023 Reporting Period

-3.7%

Appreciation/Depreciation of All Reported Holdings1

-9.0%

Average Mark-Up/Mark-Down Across All Reported Holdings2
Heal
1300.0%
Laronde
92.8%
Celonis
88.0%
Bowery
59.3%
Airtable
42.8%
Sila Nano
23.5%
Lightmatter
15.3%
Lime
12.5%
Omada Health
11.8%
Tipalti
10.9%
VideoAmp
10.4%
Klarna
10.0%
Tory Burch
9.9%
Clio
9.2%
Astranis
9.0%
Arctic Wolf
8.1%
Bytedance
8.1%
Evozyne
8.0%
Bombas
7.5%
Wugen
6.8%
Astera Labs
6.3%
Databricks
5.9%
Stripe
5.9%
MNTN
5.7%
D2iQ
5.5%
Asapp
5.3%
Skyryse
3.6%
SiMa ai
3.5%
Rappi
3.3%
Honor Tech
2.1%
Epic Games
1.1%
Fabletics
1.0%
Moloco
0.7%
Nuro
0.7%
FlixBus
0.4%
Relativity Space
0.4%
Gusto
0.2%
PsiQuantum
0.2%
Einride
0.1%
A24 Films
0.0%
Cadre
0.0%
Cross River
0.0%
Element Bio
0.0%
Enevate
0.0%
Envoy
0.0%
Epirus
0.0%
Faraday Pharma
0.0%
GupShup
0.0%
Headspace
0.0%
Highspot
0.0%
Houzz
0.0%
KoBold Metals
0.0%
MadHive
0.0%
Patreon
0.0%
Phenom
0.0%
SecurityScorecard
0.0%
ServiceTitan
0.0%
SpaceX
0.0%
Tarana
0.0%
Thrasio
0.0%
Druva
-0.1%
Resilience
-0.1%
Socure
-0.1%
Savage X
-0.4%
Dataminr
-0.5%
Discord
-0.5%
Rapyd
-1.2%
Retym
-1.2%
MasterClass
-1.4%
Grammarly
-1.6%
Waymo
-1.7%
Blink Health
-1.8%
LifeMine
-2.4%
Redwood Materials
-2.9%
Chime
-3.0%
Verily
-3.4%
Dragonfly Therapeutics
-3.6%
Saluda Medical
-3.6%
Fanatics
-4.0%
Ant Group
-4.1%
Castle Creek
-4.3%
Rapport Therapeutics
-4.6%
Ankyra
-5.0%
Circle
-5.2%
Alif Semi
-5.3%
Aledade
-5.5%
Deep Genomics
-5.6%
Canva
-5.7%
PrognomIQ
-5.8%
Kardium
-5.9%
Kartos Therapeutics
-6.8%
Cleerly
-7.1%
T-Knife
-7.3%
Starling Bank
-7.4%
ABL Space
-7.6%
Asimov
-8.5%
Checkr
-8.7%
Conformal Medical
-8.8%
Genesis Therapeutics
-9.2%
Boundless Bio
-9.3%
Quell
-9.8%
Altos Labs
-10.0%
Sonoma Bio
-10.0%
Treeline Bio
-10.0%
FogPharma
-10.2%
Galvanize
-10.9%
Odyssey Therapeutics
-10.9%
Bolt
-11.3%
Freenome
-11.6%
Algolia
-11.8%
Reddit
-12.1%
SalioGen
-12.4%
Diamond Foundry
-12.7%
MOD Pizza
-12.7%
Thriveworks
-13.0%
Unqork
-13.7%
Scorpion Therapeutics
-14.2%
Signifyd
-14.2%
Insitro
-14.3%
Generate Bio
-15.0%
Goop
-15.8%
Seismic
-15.9%
RefleXion Medical
-16.7%
Meesho
-17.3%
CelLink
-19.5%
SambaNova
-19.5%
BETA Technologies
-20.3%
Color Genomics
-20.6%
Skyhawk
-21.4%
Xsight Labs
-21.6%
Tempus Labs
-22.4%
Menlo Micro
-23.2%
Caidya (dMed)
-24.6%
X Holdings
-26.2%
ElevateBio
-27.8%
goPuff
-28.0%
Inscripta
-28.8%
Caris
-31.8%
Pine Labs
-34.6%
Adimab
-34.8%
DNA Script
-35.1%
Bright Peak
-37.4%
GOAT
-40.4%
HaulHub
-40.5%
Rad Power
-53.9%
FLEXE
-57.1%
BYJU's
-72.3%
Farmers Business Network
-82.2%
JUUL
-86.8%
Magic Leap
-90.7%
AgBiome
-94.9%

1 Dollar-weighted return on all reported holdings
2 Equal-weighted mark-up or mark-down across all reported holdings

This quarter, reporting holders marked down their private portfolios by 3.7% ($ weighted) with an average mark-down of 9% (equal weighted). The period saw five companies declining for every two advancing companies.

Laronde experienced the most significant mark-up, followed by Celonis, Bowery and Airtable. AI & Machine Learning, Marketing Tech and Data & Analytics saw the largest mark-ups across sectors.

AgBiome experienced the most significant mark-down, while Magic Leap, JUUL and Farmers Business Network also experienced crucial mark-downs. Among sectors, AgTech, EdTech, and FoodTech saw the largest mark-downs.

Comparison of ZX Index Value vs. Fund Marks

CompaniesZX Index Value vs. Fund Marks
Figma+83.40%
Intercom+72.30%
goPuff+68.10%
Socure+68.10%
Sila Nano+56.60%
Lime+54.80%
Liquid Death+51.40%
Algolia+36.10%
SpaceX+24.90%
Whoop+21.30%
Dataminr+19.80%
Circle+18.00%
Klarna+14.90%
Carta+12.10%
Phenom+10.70%
GupShup+10.50%
6Sense+10.10%
Harness+9.10%
Stripe+7.70%
FLEXE+4.50%
Scale AI+4.30%
Druva+3.80%
Redwood Materials+3.30%
Discord+3.20%
CoreWeave+0.40%
Cohesity-0.10%
Canva-2.30%
Astera Labs-2.50%
Tekion-4.70%
Databricks-4.90%
Moloco-5.10%
Gusto-5.30%
Patreon-5.70%
Flexport-6.00%
ThoughtSpot-7.30%
Highspot-7.60%
ServiceTitan-7.70%
Reddit-8.80%
Cross River-15.10%
Chime-17.20%
Relativity Space-22.50%
Fanatics-22.60%
Epic Games-23.30%
Arctic Wolf-27.70%
SecurityScorecard-31.40%
Cart.com-39.00%
Airtable-47.00%
Bytedance-47.60%
Checkr-55.00%
VideoAmp-59.70%
SambaNova-59.90%
Celonis-68.50%

In January, 40% of ZX Index companies showed a difference of 10% or less compared to Fund Marks, and 57% of ZX Index companies showed a difference of 20% or less compared to Fund Marks. Among the companies, Figma, Intercom, goPuff and Socure had the highest positive variance in reported marks versus ZX Index Values. Celonis, SambaNova, VideoAmp and Checkr had the highest negative variance in reported marks versus ZX Index Values.

Highest Variance in Reported Marks
CompanyNormalized Std Dev3$ Weighted AvgMaxMin
Farmers Business Network.55$4.26$19.21$2.50
Rad Power.39$0.71$1.04$0.42
VAST Data.33$13.20$22.00$10.95
Rappi.26$37.45$53.33$31.36
Rapyd.24$56.67$67.55$39.37

3 Normalized Standard Deviation is used to express the measure of spread across reported marks and allows for comparison between companies independent of their price per share based on a dollar-weighted average.

This period, Farmers Business Network ($2.50 - $19.21) saw the highest share price variance across funds followed by Rad Power ($0.42 - $1.04) and VAST Data ($10.95 - $22.00).

Positive Trend Reversal4 (# = consecutive prior qtrs marked down or flat)
Negative Trend Reversal5 (# = consecutive prior qtrs marked up or flat)
Positive Trend Reversal4 (# = consecutive prior qtrs marked down or flat)
Sila Nano
10
Bowery
9
Celonis, Rappi
8
ABL Space, Bombas, Nuro
7
Negative Trend Reversal5 (# = consecutive prior qtrs marked up or flat)
Kardium
9
Resilience
9
Fanatics, Magic Leap
8
Grammarly
6

4 Positive Trend Reversal reflects an individual holding marked up after consecutive quarterly periods marked down or flat
5 Negative Trend Reversal reflects an individual holding marked down after consecutive quarterly periods marked up or flat

Sila Nano, saw its first positive reversals in ten quarters years while Bowery saw its first positive reversal in nine quarters. Kardium and Resilience saw their first negative reversal in nine quarters while Fanatics and Magic Leap saw their first negative reversal in two years.

Disclaimer

This report is based on data reported by 300+ funds and $51 billion+ of value. Many holders of private company shares do not report their holding values and are thus not included in this report’s dataset. Further, many venture-backed private companies are not held by any reporting funds and are thus not included in this report. As such, this report should not be construed as providing a complete picture of shareholder sentiment or venture-backed private company performance. This report does not constitute investment advice or a "research report" as defined by FINRA Rules.

The “ZX Index Value” is derived by applying proprietary weightings to the order flow data collected for the stated period (both bids and asks), based on the order type (firm order or indication of interest) and whether the order has been executed, with greater weight given to more recent orders.

Zanbato, Inc. (“Zanbato”) prepares and disseminates market information about venture-backed private company securities, and the current bids and offers for those securities listed on the ATS operated by Zanbato (“ZX”). The information provided in this report has been prepared by sales, trading, or other non-research functions. Pricing indications and macro commentary are provided for factual information purposes only. This report is not intended to assess the individual merits of a particular investment or strategy, does not constitute a recommendation to buy or sell any financial instrument or to participate in any trading strategy and should not be construed as such. This report does not constitute investment advice. Certain information in this report has been obtained from third party sources and, while such information is believed by Zanbato to be reliable, it has not been independently verified by Zanbato and Zanbato shall not be responsible or liable, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with any use of, or reliance on, such third party information. Furthermore, the information contained in this report may not be current due to, among other things, changes in the financial markets or economic environment. Zanbato does not, and has no obligation to, update any such information contained in this report. Any prices or quotations contained herein are indicative only, do not represent firm quotes as to either price or size and should not be used for valuation purposes.

yukacon_arrow_up_right